FibroGen (FGEN) Competitor Comparison
We are evaluating the key criteria listed to compare FibroGen (FGEN) against its competitors in the Biotechnology industry.
Market Capitalization
223 / 368Gross Profits
257 / 278Total Revenue
71 / 300EBITDA
294 / 337Free Cashflow
325 / 352Quick Ratio
315 / 357Earnings per Share
236 / 359Dividend yield
0 / 5Total Cash
131 / 358Performance 3 years
338 / 368Performance 5 years
344 / 368Performance 10 years
304 / 368Linearity 3 years
213 / 367Linearity 5 years
234 / 367Linearity 10 years
111 / 368Total Rank
126 / 368Dividend Rank
129 / 368Valuation Rank
251 / 368Piotroski Rank
348 / 368Muliplier Rank
102 / 368EBITDA - FGEN ranking 294 / 337
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.